Journals / Turkish Journal of Medical Sciences / 2000 / Cilt: 30 - Sayı: 6

The Importance of Anticardiolipin Antibody and Antiplatelet Antibody in the Development of Thrombocytopenia in Cirrhosis

Pages
589–594
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: There was a significant difference in ultrasonographic spleen size between the patients with and without thrombocytopenia (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose of the present study was to investigate the effects of the presence of hypersplenism, antiplatelet antibody and anticardiolipin antibody, which are thought to be important factors, on the development of thrombocytopenia in patients with cirrhosis with viral etiology.
📊
Key Findings & Data:Methods: This study includes 44 patients with cirrhosis related to HBV and HCV, and 12 healthy control subjects.
💡
Conclusion & Impact:Results: There was a significant difference in ultrasonographic spleen size between the patients with and without thrombocytopenia (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Cirrhosis · thrombocytopenia · anticardiolipin antibody

Abstract

Objective: The purpose of the present study was to investigate the effects of the presence of hypersplenism, antiplatelet antibody and anticardiolipin antibody, which are thought to be important factors, on the development of thrombocytopenia in patients with cirrhosis with viral etiology. Methods: This study includes 44 patients with cirrhosis related to HBV and HCV, and 12 healthy control subjects. Spleen size was evaluated by ultrasonography, the presence of antiplatelet antibody by flow cytometry, and IgG and IgM isotypes of anticardiolipin anti- body by enzyme immunoassay. Results: There was a significant difference in ultrasonographic spleen size between the patients with and without thrombocytopenia (p

Özet

Objective: The purpose of the present study was to investigate the effects of the presence of hypersplenism, antiplatelet antibody and anticardiolipin antibody, which are thought to be important factors, on the development of thrombocytopenia in patients with cirrhosis with viral etiology. Methods: This study includes 44 patients with cirrhosis related to HBV and HCV, and 12 healthy control subjects. Spleen size was evaluated by ultrasonography, the presence of antiplatelet antibody by flow cytometry, and IgG and IgM isotypes of anticardiolipin anti- body by enzyme immunoassay. Results: There was a significant difference in ultrasonographic spleen size between the patients with and without thrombocytopenia (p

🔖

Cite This Article

YAVUZ, H., SARIÇAM, T., ERENOĞLU, E., VARDARELİ, E., GÜLBAŞ, Z., ÖZAKYOL, A. (2022). The Importance of Anticardiolipin Antibody and Antiplatelet Antibody in the Development of Thrombocytopenia in Cirrhosis. Turkish Journal of Medical Sciences, Cilt: 30 - Sayı: 6, 589–594. https://ajindex.com/articles/612380

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...